IL17A and hepatocellular carcinoma: Notably, the modulation of the immune cell compartment and the reduction in the pro-inflammatory chemokine IL-17 have been identified as mechanisms of action of a probiotic mixture tested in HCC mice, leading to the improvement of gut dysbiosis and, in particular, to the enrichment of A. muciniphila [126].